BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 28760161)

  • 1. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
    Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
    Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice.
    Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H
    Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APP Osaka Mutation in Familial Alzheimer's Disease-Its Discovery, Phenotypes, and Mechanism of Recessive Inheritance.
    Tomiyama T; Shimada H
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
    Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
    Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.
    Kulic L; McAfoose J; Welt T; Tackenberg C; Späni C; Wirth F; Finder V; Konietzko U; Giese M; Eckert A; Noriaki K; Shimizu T; Murakami K; Irie K; Rasool S; Glabe C; Hock C; Nitsch RM
    Transl Psychiatry; 2012 Nov; 2(11):e183. PubMed ID: 23149447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
    Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
    Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
    Tackenberg C; Kulic L; Nitsch RM
    PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo.
    Tomiyama T; Matsuyama S; Iso H; Umeda T; Takuma H; Ohnishi K; Ishibashi K; Teraoka R; Sakama N; Yamashita T; Nishitsuji K; Ito K; Shimada H; Lambert MP; Klein WL; Mori H
    J Neurosci; 2010 Apr; 30(14):4845-56. PubMed ID: 20371804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
    J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
    Zhao G; Liu HL; Zhang H; Tong XJ
    Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A
    Palavicini JP; Wang C; Chen L; Hosang K; Wang J; Tomiyama T; Mori H; Han X
    Acta Neuropathol Commun; 2017 Jul; 5(1):56. PubMed ID: 28750656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.
    Shimada H; Minatani S; Takeuchi J; Takeda A; Kawabe J; Wada Y; Mawatari A; Watanabe Y; Shimada H; Higuchi M; Suhara T; Tomiyama T; Itoh Y
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32580499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.